Pressure Biosciences Inc (PBIO)
Pressure BioSciences, Inc. is a life sciences tools and services company listed on OTC Markets under the ticker PBIO. The company develops and sells high-pressure technology-based instruments, consumables, and related services for use in life sciences and other industries. Its technology portfolio includes Ultra Shear Technology, which is used to create water-soluble, bioavailable nanoemulsion formulations; BaroFold Technology, which is designed to support protein biotherapeutic development and manufacturing efficiency; and Pressure Cycling Technology, which applies alternating pressure cycles to influence biomolecular interactions in sample preparation.
The company’s product range includes Barocycler instruments, associated consumables, UltraShear systems, and application-specific kits. In addition, it markets products for pain relief, skincare, personal wellness, athletic recovery, and specialized pet care. Pressure BioSciences serves academic researchers, government agencies, biotechnology and pharmaceutical companies, other life science organizations, and food and beverage laboratories. Founded in 1978 and headquartered in Canton, Massachusetts, the company was previously known as Boston Biomedica, Inc. and adopted its current name in 2014.
Jump directly to the stock analysis sections supported by the latest available data.
| Ticker | Fair Value | Analyst Price Target | Analyst Target Upside/Downside | Overall Financial Health | Dividend Yield | Next Earnings Date | Market Cap |
|---|---|---|---|---|---|---|---|
|
OTC-PBIO
|
Not available
|
Not available
|
Not available
|
Weak
|
0.0%
|
November 24, 2026
|
8.593 K
|
